Biopharmaceutical studies on aminoethanesulfonylphenetidine and related compounds. 3. Drug in blood.
D000284:Administration, Oral; D000814:Aniline Compounds / Q000008:administration & dosage / Q000097:blood* / Q000494:pharmacology; D000818:Animals; D001702:Biopharmaceutics; D004912:Erythrocytes / Q000187:drug effects; D005019:Ethyl Ethers / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology; D006461:Hemolysis / Q000187:drug effects; D006868:Hydrolysis; D007275:Injections, Intravenous; D008297:Male; D008706:Methemoglobin / Q000096:biosynthesis; D051379:Mice; D009539:Nicotinic Acids / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology; D010628:Phenetidine / Q000031:analogs & derivatives; D011817:Rabbits; D051381:Rats; D013654:Taurine / Q000008:administration & dosage / Q000097:blood* / Q000494:pharmacology / Q000031:analogs & derivatives
D000814:Aniline Compounds; D005019:Ethyl Ethers; D009539:Nicotinic Acids; D010628:Phenetidine; D013654:Taurine; C002073:taurinophenetidine; D008706:Methemoglobin